StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2023 - 07 - 12
1
2022 - 11 - 30
1
2022 - 09 - 05
1
2022 - 03 - 18
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 12 - 14
1
2021 - 11 - 12
1
2021 - 08 - 18
1
2021 - 07 - 21
1
2021 - 06 - 22
1
Sector
Health technology
11
Manufacturing
1
Tags
Acquire
7
Agreement
5
Application
6
Approval
7
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
5
Cardiovascular
5
Collaboration
8
Companies
6
Conference
20
Device
5
Diabetes
34
Disease
18
Drug
18
Earnings
8
Europe
10
Events
22
Expansion
7
Expected
10
Fda
11
Financial
7
Financial results
7
Genetown
7
Global
45
Growing
5
Growth
33
Hormone
7
Insulin
32
Iot
6
Kidney
5
Liver
11
Market
78
Money
7
N/a
516
Obesity
16
People
11
Pharma
81
Pharmaceutical
12
Phase 2
7
Phase 3
6
Program
10
Reach
9
Report
38
Repurchase
96
Research
34
Results
20
S
42
Sales
13
Sanofi
7
Study
6
Technology
10
Therapeutics
26
Therapy
11
Treatment
34
Trial
32
Trials
8
Update
12
Entities
89bio, inc.
1
Akero therapeutics, inc.
1
Alnylam pharmaceuticals, inc.
4
Antares pharma, inc.
1
Astrazeneca plc
1
Becton, dickinson and company
5
Bristol-myers squibb company
1
Eli lilly and company
9
Endo international plc
1
Galectin therapeutics inc.
2
Insulet corporation
5
Johnson & johnson
1
Lipocine inc.
2
Madrigal pharmaceuticals, inc.
2
Medtronic plc
5
Novo nordisk a/s
11
Precision biosciences, inc.
1
Sagimet biosciences inc.
1
Sanofi
4
Terumo corp
1
Symbols
ABT
11
ABUS
10
AKRO
18
ALBO
10
ALGS
17
ALNY
16
ALT
8
AMGN
7
AMZN
9
ARVL
31
ASMB
14
AZN
18
AZNCF
15
BDX
16
BHC
7
CANF
12
CBAY
10
CTRM
9
DADA
17
ERIC
7
ETNB
8
FDX
8
FNCTF
14
GALT
15
GILD
11
GLAXF
10
GNFT
12
GOLD
8
GP
8
GSK
15
HEPA
20
HIL
8
ICPT
16
INTC
9
IVA
11
JNJ
26
LI
17
LLY
19
MDGL
19
MDT
13
MIRM
13
MMM
8
MS
10
NDAQ
9
NIO
21
NVO
11
NVS
20
NVSEF
11
PHG
13
PODD
11
SNOW
9
SNY
22
SNYNF
15
T
8
TAK
16
TEVJF
8
TRMD
8
VIR
10
VSH
9
VZ
8
Exchanges
Nasdaq
11
Nyse
11
Crawled Date
2023 - 07 - 12
1
2022 - 11 - 30
1
2022 - 09 - 05
1
2022 - 03 - 18
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 12 - 14
1
2021 - 11 - 12
1
2021 - 08 - 18
1
2021 - 07 - 21
1
2021 - 06 - 22
1
Crawled Time
07:00
1
08:00
1
12:00
1
12:15
1
13:00
1
14:00
2
16:00
1
17:00
1
19:00
1
21:00
1
Source
www.biospace.com
4
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Liver
symbols :
NVO
save search
Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight
Published:
2023-07-12
(Crawled : 21:00)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-19.53%
|
O:
1.7%
H:
0.01%
C:
-0.32%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
70.4%
|
O:
-0.08%
H:
0.46%
C:
-1.26%
MDGL
|
$222.18
-2.7%
-2.8%
270K
|
Health Technology
|
0.81%
|
O:
0.41%
H:
3.34%
C:
1.43%
LPCN
|
$5.47
2.82%
2.74%
21K
|
Health Technology
|
20.36%
|
O:
0.11%
H:
2.15%
C:
1.02%
GALT
|
$3.36
-0.59%
-0.6%
150K
|
Health Technology
|
116.67%
|
O:
0.64%
H:
7.01%
C:
5.1%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-28.1%
|
O:
0.69%
H:
1.02%
C:
0.29%
AKRO
|
$20.535
-4.93%
-5.19%
760K
|
Health Technology
|
-54.47%
|
O:
0.78%
H:
1.1%
C:
-0.15%
cirrhosis
liver
growth
market
iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
Published:
2022-11-30
(Crawled : 14:00)
- biospace.com/
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
2.62%
|
O:
2.1%
H:
0.56%
C:
0.56%
DTIL
|
$10.77
-6.43%
-6.87%
71K
|
Health Technology
|
724.62%
|
O:
1.54%
H:
4.55%
C:
3.79%
treatment
rare
liver
Liver Fibrosis Market to Surge at a CAGR of 15.9% by 2032 | DelveInsight
Published:
2022-09-05
(Crawled : 16:00)
- prnewswire.com
SGMT
|
$3.97
-2.46%
-2.52%
340K
|
Health Technology
|
Email alert
Add to watchlist
ETNB
|
$8.9
-2.84%
-2.92%
680K
|
Health Technology
|
Email alert
Add to watchlist
MDGL
|
$222.18
-2.7%
-2.8%
270K
|
Health Technology
|
Email alert
Add to watchlist
LPCN
|
$5.47
2.82%
2.74%
21K
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
GALT
|
$3.36
-0.59%
-0.6%
150K
|
Health Technology
|
Email alert
Add to watchlist
fibrosis
liver
market
Insulin Delivery Devices Market to Hit $39,371.8 Million Revenue by 2030, says P&S Intelligence
Published:
2022-03-18
(Crawled : 07:00)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
15.28%
|
O:
0.66%
H:
0.0%
C:
0.0%
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-26.16%
|
O:
2.46%
H:
0.6%
C:
0.41%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
162.96%
|
O:
0.12%
H:
1.93%
C:
0.63%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-11.03%
|
O:
0.68%
H:
0.55%
C:
0.24%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.4%
|
O:
-0.62%
H:
1.07%
C:
0.89%
PODD
|
$164.71
-0.93%
-0.94%
590K
|
Health Technology
|
-33.03%
|
O:
-0.35%
H:
5.54%
C:
5.11%
device
liver
intel
insulin
At 9.7% CAGR, Insulin Delivery Devices Market Size to hit USD 33.05 Billion in 2028, Says Brandessence Market Research
Published:
2022-01-03
(Crawled : 12:00)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
11.19%
|
O:
-2.14%
H:
0.0%
C:
0.0%
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-23.56%
|
O:
-0.14%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
171.8%
|
O:
-0.78%
H:
0.0%
C:
0.0%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-8.14%
|
O:
-0.43%
H:
0.0%
C:
0.0%
PODD
|
$164.71
-0.93%
-0.94%
590K
|
Health Technology
|
-37.51%
|
O:
1.07%
H:
0.0%
C:
0.0%
ce mark
device
research
liver
insulin
Global $19 Billion Home-Use Insulin Delivery Devices Markets, 2015-2020 & 2021-2030
Published:
2021-12-20
(Crawled : 19:00)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
20.28%
|
O:
1.2%
H:
1.62%
C:
1.37%
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-20.55%
|
O:
0.45%
H:
2.78%
C:
1.68%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
184.94%
|
O:
0.2%
H:
0.74%
C:
0.33%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-8.48%
|
O:
0.57%
H:
0.63%
C:
-0.8%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-7.07%
|
O:
0.76%
H:
0.67%
C:
0.45%
PODD
|
$164.71
-0.93%
-0.94%
590K
|
Health Technology
|
-35.28%
|
O:
0.29%
H:
3.22%
C:
3.08%
device
liver
insulin
Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight
Published:
2021-12-14
(Crawled : 17:00)
- prnewswire.com
TRUMF
|
$17.112
-17.59%
1.5K
|
Health Technology
|
-59.59%
|
O:
-1.42%
H:
0.02%
C:
0.02%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-5.03%
|
O:
-3.62%
H:
0.0%
C:
-0.56%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
26.12%
|
O:
-1.44%
H:
5.82%
C:
1.91%
TRUMY
|
$16.69
0.79%
54K
|
Manufacturing
|
-59.75%
|
O:
-1.37%
H:
0.68%
C:
0.37%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
7.92%
|
O:
-1.8%
H:
0.08%
C:
-0.43%
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-29.7%
|
O:
-0.2%
H:
0.66%
C:
-0.52%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-12.2%
|
O:
1.9%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
205.54%
|
O:
0.82%
H:
0.92%
C:
0.66%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-15.63%
|
O:
2.71%
H:
2.77%
C:
1.21%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-8.62%
|
O:
-0.3%
H:
0.1%
C:
-1.63%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.36%
|
O:
-0.51%
H:
0.0%
C:
0.0%
PODD
|
$164.71
-0.93%
-0.94%
590K
|
Health Technology
|
-37.17%
|
O:
-0.82%
H:
0.38%
C:
-2.71%
ENDP
|
$0.2926
-9.6%
|
Health Technology
|
-93.51%
|
O:
-5.76%
H:
7.53%
C:
0.47%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
25.72%
|
O:
0.33%
H:
0.0%
C:
0.0%
ATRS
|
$5.59
0.0%
|
Health Technology
|
74.14%
|
O:
-0.31%
H:
0.7%
C:
-0.63%
drug
liver
growing
drug delivery
Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021
Published:
2021-11-12
(Crawled : 14:00)
- biospace.com/
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
9.62%
|
O:
-0.47%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
185.43%
|
O:
-0.49%
H:
0.0%
C:
0.0%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-17.78%
|
O:
-2.06%
H:
0.0%
C:
0.0%
disease
liver disease
phase 1
liver
trial
Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence
Published:
2021-08-18
(Crawled : 08:00)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
18.68%
|
O:
0.04%
H:
0.72%
C:
-0.91%
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-39.52%
|
O:
0.03%
H:
0.28%
C:
-1.12%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
175.3%
|
O:
-0.26%
H:
1.01%
C:
-1.28%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-8.86%
|
O:
0.07%
H:
0.3%
C:
-2.11%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-13.43%
|
O:
0.17%
H:
1.16%
C:
-0.04%
PODD
|
$164.71
-0.93%
-0.94%
590K
|
Health Technology
|
-45.1%
|
O:
0.21%
H:
0.12%
C:
-2.14%
insulin
device
liver
Dicerna Announces Interim Results From Phase 1 Trial of Belcesiran for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published:
2021-07-21
(Crawled : 13:00)
- biospace.com/
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
42.3%
|
O:
0.9%
H:
0.72%
C:
0.58%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
219.45%
|
O:
0.58%
H:
0.42%
C:
0.38%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-20.75%
|
O:
0.45%
H:
0.0%
C:
-2.13%
disease
liver disease
treatment
phase 1
results
liver
trial
phase 2
phase 3
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published:
2021-06-22
(Crawled : 12:15)
- biospace.com/
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
50.67%
|
O:
-0.39%
H:
0.27%
C:
-0.21%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
237.17%
|
O:
-0.02%
H:
0.44%
C:
-0.53%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-15.24%
|
O:
0.08%
H:
1.01%
C:
0.9%
disease
liver disease
treatment
phase 2
liver
trial
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.